Receiving Modified Chemotherapy Followed With Radical Resection After Neoadjuvant Chemotherapy

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
For patients undergoing postoperative therapy for locally advanced gastric cancer after neoadjuvant chemotherapy, we assessed the utility of graded histologic regression of \<50% as the criterion of treatment change. Sixty patients will be enrolled to randomize into two groups:receiving modified chemotherapy and receiving the original chemotherapy.
Epistemonikos ID: 37e110166231c396abf51584f214e14428fe0a71
First added on: May 21, 2024